Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
暂无分享,去创建一个
M. Onizuka | Y. Atsuta | E. Kondo | N. Maseki | S. Kusumoto | K. Matsuoka | T. Fukuda | H. Nakazawa | Y. Shimomura | I. Mizuno | M. Yamaguchi | A. Shinohara | T. Ashida | Minoru Kanaya | Takahide Ara | T. Kuriyama | Shohei Mizuno | Y. Usui | K. Kamijo | Sung-Won Kim | Takuro Kuriyama | Kimimori Kamijo | Akihito Shinohara